Kellerhals Carrard advised Vifor Pharma on this transaction. Vifor Pharma Participations AG (Vifor Pharma) closed its divestment transaction regarding its finished drug product manufacturing business with...
You must be a Standard 1 Year member to access this content.
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to STILLE in this transaction. Stille AB, a medical device company whose shares are listed on the Nasdaq First North...
You must be a Standard 1 Year member to access this content.
